- Home
- TTNP vs MTNB Comparison
TTNP vs MTNB Comparison
Compare TTNP & MTNB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TTNP
- MTNB
- Stock Information
- Founded
- TTNP 1991
- MTNB 2013
- Country
- TTNP United States
- MTNB United States
- Employees
- TTNP N/A
- MTNB N/A
- Industry
- TTNP Biotechnology: Biological Products (No Diagnostic Substances)
- MTNB Biotechnology: Pharmaceutical Preparations
- Sector
- TTNP Health Care
- MTNB Health Care
- Exchange
- TTNP Nasdaq
- MTNB Nasdaq
- Market Cap
- TTNP 3.4M
- MTNB 3.6M
- IPO Year
- TTNP 1996
- MTNB N/A
- Fundamental
- Price
- TTNP $4.65
- MTNB $0.93
- Analyst Decision
- TTNP
- MTNB Hold
- Analyst Count
- TTNP 0
- MTNB 1
- Target Price
- TTNP N/A
- MTNB N/A
- AVG Volume (30 Days)
- TTNP 81.0K
- MTNB 379.6K
- Earning Date
- TTNP 05-14-2025
- MTNB 05-15-2025
- Dividend Yield
- TTNP N/A
- MTNB N/A
- EPS Growth
- TTNP N/A
- MTNB N/A
- EPS
- TTNP N/A
- MTNB N/A
- Revenue
- TTNP N/A
- MTNB N/A
- Revenue This Year
- TTNP N/A
- MTNB N/A
- Revenue Next Year
- TTNP N/A
- MTNB N/A
- P/E Ratio
- TTNP N/A
- MTNB N/A
- Revenue Growth
- TTNP N/A
- MTNB N/A
- 52 Week Low
- TTNP $3.03
- MTNB $0.47
- 52 Week High
- TTNP $14.80
- MTNB $9.60
- Technical
- Relative Strength Index (RSI)
- TTNP 53.37
- MTNB 68.54
- Support Level
- TTNP $4.16
- MTNB $0.77
- Resistance Level
- TTNP $5.12
- MTNB $0.96
- Average True Range (ATR)
- TTNP 0.44
- MTNB 0.12
- MACD
- TTNP -0.01
- MTNB 0.01
- Stochastic Oscillator
- TTNP 51.54
- MTNB 45.43
About TTNP Titan Pharmaceuticals Inc.
Titan Pharmaceuticals Inc is a development stage company developing proprietary therapeutics with utilizing ProNeura long-term, continuous drug delivery technology. The ProNeura technology has the potential to be used in developing products for treating a number of chronic conditions, where maintaining consistent, around-the-clock blood levels of medication may benefit the patient and improve medical outcomes.
About MTNB Matinas Biopharma Holdings Inc.
Matinas BioPharma Holdings Inc is a clinical-stage biopharmaceutical company with a focus on identifying and developing novel pharmaceutical products. The firm's pipeline includes MAT2203, MAT2501, and others.